SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001906324-24-000032
Filing Date
2024-05-09
Accepted
2024-05-08 18:04:23
Documents
82
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q qdel-20240331.htm   iXBRL 10-Q 1003740
2 EX-31.1 ex3113312024.htm EX-31.1 9678
3 EX-31.2 ex3123312024.htm EX-31.2 9789
4 EX-32.1 ex3213312024.htm EX-32.1 5583
  Complete submission text file 0001906324-24-000032.txt   6611455

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT qdel-20240331.xsd EX-101.SCH 45768
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT qdel-20240331_cal.xml EX-101.CAL 92337
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT qdel-20240331_def.xml EX-101.DEF 206395
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT qdel-20240331_lab.xml EX-101.LAB 577995
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT qdel-20240331_pre.xml EX-101.PRE 426014
86 EXTRACTED XBRL INSTANCE DOCUMENT qdel-20240331_htm.xml XML 1002422
Mailing Address 9975 SUMMERS RIDGE ROAD SAN DIEGO CA 92121
Business Address 9975 SUMMERS RIDGE ROAD SAN DIEGO CA 92121 (858) 552-1100
QuidelOrtho Corp (Filer) CIK: 0001906324 (see all company filings)

IRS No.: 874496285 | Fiscal Year End: 0101
Type: 10-Q | Act: 34 | File No.: 001-41409 | Film No.: 24927811
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)